Аcute transverse myelitis and Guillain – Barre overlap syndrome in a patient with СOVID-19

We report a case of transverse myelitis and Guillain–Barre syndrome (GBS) overlap in the 42-year-old patient with moderate course of Coronavirus disease 2019 (СOVID-19). Nasopharyngeal SARS-CoV 2 RT-PCR was positive. Severe neck pain developed in this patient on the 5-th day of СOVID-19. A few hours later weakness in the feet arised and then spread to the thighs and arms.

Quadriparesis, arefl exia in all limbs, sensory loss below the level of T4 and bladder/bowel dysfunction were present. Pyramidal signs were negative. There was no increase of COVID-19 severity at the time of neurological signs development.

Magnetic resonance imaging of the spinal cord showed the focal lesion in the C2-T1 segments, which was consistent with the features of longitudinally extensive transverse myelitis.

Along with the myelitis, acute motor axonal polyneuropathy was diagnosed. This diagnosis of GBS was supported by ascending weakness with arefl exia, albumin-cytological dissociation in cerebrospinal fl uid and the data of neuroelectrophysiological examination.

We proposed that both myelitis and GBS had disimmune nature associated with COVID-19. The other possible causes of damage to the spinal cord and peripheral nervous system were excluded.

Immunotherapy with high dose of intravenous immunoglobulins was administered. Steroids also were used taking into account the myelitis.

At the follow up in 4 months the motor functions were found to be improved nonsignifi cantly, the patient was still severe disabled.

1. Zubair A.S., McAlpine L.S., Gardin T., Farhadian S., Kuruvilla D.E., Spudich S. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review. JAMA Neurol. 2020;77(8):1018–1027. https://doi.org/10.1001/jamaneurol.2020.2065

2. Román G.C., Gracia F., Torres A., Palacios A., Gracia K., Harris D. Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 PostVaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222). Front Immunol. 2021;12:653786. https://doi.org/10.3389/fi mmu.2021.653786

3. Schulte E.C., Hauer L., Kunz A.B., Sellner J. Systematic Review of Cases of Acute Myelitis in Individuals with COVID-19. Eur J Neurol. 2021 Jun 1. https://doi.org/10.1111/ene.14952

4. Abu-Rumeileh S., Abdelhak A., Foschi M., Tumani H., Otto M. Guillain–Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases. J Neurol. 2021;268(4):1133–1170. https://doi.org/10.1007/s00415-020- 10124-x

5. Goh C., Desmond P.M., Phal P.M. MRI in transverse myelitis. J Magn Reson Imaging. 2014;40(6):1267–79. https://doi. org/10.1002/jmri.24563

6. Piradov M.A., Suponeva N.A., Grishina D.A. Polyneuropathies: algorithms of diagnostic and treatment. Moscow: Goryachaya liniya-Telekom, 2019:248 p. (In Russ.).

7. Maideniuc C, Memon AB. Acute necrotizing myelitis and acute motor axonal neuropathy in a COVID-19 patient. J Neurol. 2020;Aug9:1–3. https://doi.org/10.1007/s00415-020-10145-6

8. Valiuddin H., Skwirsk B., Paz-Arabo P. Acute transverse myelitis associated with SARS-CoV-2: A Case-Report. Brain Behav Immun Health. 2020;5:100091. https://doi.org/10.1016/j. bbih.2020.100091

9. Masuccio F.G., Barra M., Claudio G., Claudio S. A rare case of acute motor axonal neuropathy and myelitis related to SARSCoV-2 infection. J Neurol. 2020;Sep 17:1–4. https://doi. org/10.1007/s00415-020-10219-5

10. Guo F., Zhang Y.B. Clinical features and prognosis of patients with Guillain–Barré and acute transverse myelitis overlap syndrome. Clin Neurol Neurosurg. 2019;181:127–132. https://doi. org/10.1016/j.clineuro.2019.04.014

11. Stoian A., Motataianu A., Bajko Z., Balasa A. Guillain–Barré and Acute Transverse Myelitis Overlap Syndrome Following Obstetric Surgery. J Crit Care Med (Targu Mures). 2020;6(1):74–79. https://doi.org/10.2478/jccm-2020-0008

12. Murtazina A.F., Naumova E.S., Nikitin S.S., Boriskina L.M., Lagutin A.V. Bickerstaff brainstem encephalitis, acute transverse myelitis, and acute motor axonal neuropathy: diagnostic and treatment challenges in patients with concomitant syndromes. Clinical observation. Neuromuscular Diseases. 2017;7(3):56–62. (In Russ.). https://doi.org/10.17650/2222-8721-2017-7-3-56-62

13. Fokke C., van den Berg B., Drenthen J., Walgaard C., van Doorn P.A., Jacobs B.C. Diagnosis of Guillain–Barré syndrome and validation of Brighton criteria. Brain. 2014;137(Pt 1):33–43. https://doi.org/10.1093/brain/awt285

14. Hadden R.D., Cornblath D.R., Hughes R.A., Zielasek J., Hartung H.P., Toyka K.V., Swan A.V. Electrophysiological classifi cation of Guillain–Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain–Barré Syndrome Trial Group. Ann Neurol. 1998;44(5):780–8. https://doi. org/10.1002/ana.410440512

15. Srivastava A., Kundu B.K., Singh D.K. Concomitant Guillain– Barre Syndrome and Transverse Myelitis as Initial Neuropsychiatric Manifestation in a Case of Lupus: A Diagnostic Quandary. Case Rep Rheumatol. 2016;2016:5827860. https://doi. org/10.1155/2016/5827860

16. Ugurlu S., Saygin C., Uzunaslan D., Tascilar K., Ince B., Saip S. Concomitant transverse myelitis and guillain-barre syndrome after adalimumab therapy in a case with ankylosing spondylitis. Annals of the Rheumatic Diseases. 2014;73:40–4. http://dx.doi. org/10.1136/annrheumdis-2013-205124.92

17. Hamdy S.M., Abdel-Naseer M., Shehata H.S., Shalaby N.M., Hassan A., Elmazny A., Shaker E., Nada M.A.F., Ahmed S.M., Hegazy M.I., Mourad H.S., Abdelalim A., Magdy R., Othman A.S., Mekkawy D.A., Kishk N.A. Management Strategies of Patients with Neuromyelitis Optica Spectrum Disorder During the COVID-19 Pandemic Era. Ther Clin Risk Manag. 2020;16:759– 767. https://doi.org/10.2147/TCRM.S261753

18. Hughes R.A., Brassington R., Gunn A.A., van Doorn P.A. Corticosteroids for Guillain–Barré syndrome. Cochrane Database Syst Rev. 2016;10(10):CD001446. https://doi.org/10.1002/14651858. CD001446.pub5.